Industry Resource Partnership Program
Driving regenerative medicine research toward success
The CIRM Industry Resource Partnership (IRP) Program connects industry organization members with CIRM Awardees to stimulate innovation and accelerate the development of novel therapies—from discovery and translational research through to clinical stages and commercialization. Industry members have opportunities to collaborate with CIRM and engage with CIRM Awardees to help advance the cell and gene therapy industry. These relationships help overcome development bottlenecks as CIRM-Funded Projects move toward real-world solutions.
Industry members have provided critical resources to CIRM Awardees including:
- Project consultation to aid CIRM Applicants in drafting manufacturing plans and budgets
- Access to manufacturing resources for cell therapy, gene therapy, and biologics
- Access to innovative gene editing technology and cell lines
- Access to the company networks and expertise
Our partners have the opportunity to collaborate with CIRM and engage with CIRM Awardees, to help advance the cell and gene therapy industry.
The Industry Resource Partnership (IRP) Program
The Industry Resource Partnership Program seeks to make collaboration easier and to streamline knowledge sharing between industry leaders and CIRM Awardees. See below for the basic requirements and eligibility criteria set by CIRM for participating in the program.
- Feature on CIRM’s website as an Industry Resource Partner
- Exclusive invitation to attend CIRM’s annual symposia events (e.g., vendor shows)
- Opportunities to directly engage with potential clients (CIRM’s portfolio encompasses 200+ cell and gene therapy projects)
- Pre-approval inspection-ready Contract Development and Manufacturing Organization (CDMOs) facilities dedicated to cell and gene therapies
- Development and manufacturing services with experience producing current Good Manufacturing Practices (cGMP) materials under an IND
- Pre-clinical services with experience supporting GLP projects
- Bioanalytical capabilities to support non-clinical and clinical studies
- Repository services for clinical trial samples
- Services to provide strategic, technical, operational, and/or regulatory guidance to cell and gene therapy projects
- Services to support any stage of supply chain or cell sourcing
- Participant of the INFR5 Manufacturing Network
- Letter of recommendation from a CIRM Awardee
Core requirements:
- Provide detailed proposals and letter of support to CIRM prospective Awardees
- Host an annual knowledge sharing webinar accessible to CIRM Awardees
Additional requirements:
- Willingness to serve as a potential advisor for Manufacturing Network
- Preferential pricing or risk/cost sharing proposals exclusively for CIRM Awardees
- Sponsorship of CIRM Annual Symposium
- Provide internship or training opportunities to CIRM Education Programs or the INFR5 Manufacturing Network
- Serve as an advisor to one of CIRM’s Clinical Advisory Panels or other CIRM panel
Interested partners will be asked to provide a one-page summary of their services and to agree to at least two requirements by signing a Memorandum of Understanding (MOU) with CIRM.
Industry Resource Partners
Below is our current list of partners and their capabilities and offerings. To learn more about preferential pricing or partner discounts available through the IRP, contact our partners directly or reach us at preclinical@cirm.ca.gov. Partners also periodically host informational webinars about their services—visit our YouTube Channel to learn more.